Unknown

Dataset Information

0

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

ABSTRACT: We report on whole-exome sequencing (WES) of 213 melanomas. Our analysis established NF1, encoding a negative regulator of RAS, as the third most frequently mutated gene in melanoma, after BRAF and NRAS. Inactivating NF1 mutations were present in 46% of melanomas expressing wild-type BRAF and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2. Functional studies showed that NF1 suppression led to increased RAS activation in most, but not all, melanoma cases. In addition, loss of NF1 did not predict sensitivity to MEK or ERK inhibitors. The rebound pathway, as seen by the induction of phosphorylated MEK, occurred in cells both sensitive and resistant to the studied drugs. We conclude that NF1 is a key tumor suppressor lost in melanomas, and that concurrent RASopathy gene mutations may enhance its role in melanomagenesis.

SUBMITTER: Krauthammer M 

PROVIDER: S-EPMC4916843 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

We report on whole-exome sequencing (WES) of 213 melanomas. Our analysis established NF1, encoding a negative regulator of RAS, as the third most frequently mutated gene in melanoma, after BRAF and NRAS. Inactivating NF1 mutations were present in 46% of melanomas expressing wild-type BRAF and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2. Functional studies showed that NF1 suppression led to increased RAS activation in  ...[more]

Similar Datasets

Unknown Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations.
| S-EPMC5045390 | biostudies-literature
Unknown Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
| S-EPMC5522195 | biostudies-literature
Unknown Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
| S-EPMC3432702 | biostudies-literature
Unknown Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
| S-EPMC3673022 | biostudies-literature
Unknown Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung.
| S-EPMC5035874 | biostudies-literature
Unknown Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
| S-EPMC5470740 | biostudies-literature
Unknown Whole-exome sequencing identifies compound heterozygous mutations in WDR62 in siblings with recurrent polymicrogyria.
| S-EPMC3616765 | biostudies-literature
Unknown Whole-exome sequencing of rectal cancer identifies locally recurrent mutations in the Wnt pathway.
| S-EPMC8544332 | biostudies-literature
Unknown Exome sequencing identifies novel and recurrent mutations in GJA8 and CRYGD associated with inherited cataract.
| S-EPMC4240822 | biostudies-literature
Unknown Exome sequencing identifies PDE4D mutations in acrodysostosis.
| S-EPMC3322224 | biostudies-literature